DuPont
DD
$138.33
-0.09%
DuPont de Nemours, Inc. is a diversified global specialty chemicals company that provides advanced materials, technologies, and solutions for industries including healthcare, water, construction, automotive, aerospace, and electronics. Formed in 2019 from the DowDuPont merger and subsequent separations, DuPont operates as a focused specialty chemicals player with a portfolio spanning electronics, water, and protection segments. The company is currently navigating a transformation phase, highlighted by recent strong Q1 results, pricing power, and an accelerated stock buyback, while also managing the impact of portfolio changes and market cyclicality. Investors are focused on DuPont's ability to sustain growth through innovation and operational efficiency amidst a challenging macroeconomic environment.…
DD
DuPont
$138.33
Related headlines
Investment Opinion: Should I buy DD Today?
Rating & Thesis: Based on the analysis, we rate DuPont as a Buy. The company is undergoing a strategic transformation, focusing on high-growth segments like electronics and water, which should drive long-term value. The analyst consensus is a Buy with an average target price of $170, implying an upside of 22.9% from the current price of $138.33.
Sign up to view all
DD 12-Month Price Forecast
The AI assessment is bullish, driven by the attractive valuation on forward earnings and the positive analyst sentiment. The low PEG ratio suggests the market is not fully pricing in the expected growth, providing a margin of safety. However, the confidence is medium due to the recent revenue declines and the uncertainty around the strategic transformation. If the company can demonstrate sustained revenue growth and margin expansion in the coming quarters, the stance would be upgraded to high confidence. Conversely, if revenue continues to decline or margins compress, the stance would be downgraded to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DuPont's 12-month outlook, with a consensus price target around $170.00 and implied upside of +22.9% versus the current price.
Average Target
$170.00
0 analysts
Implied Upside
+22.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$156 - $186
Analyst target range
The target price range spans from a low of $156.00 to a high of $186.00, representing a spread of $30.00, which suggests moderate uncertainty. The high target of $186.00 implies a potential upside of 34.5% and likely assumes successful execution of growth initiatives, margin expansion, and continued pricing power. The low target of $156.00 still offers a 12.8% upside, reflecting a more conservative outlook that factors in potential macroeconomic headwinds or operational challenges. The relatively tight range indicates analysts have a fairly consistent view of DuPont's prospects, with no extreme bearish scenarios. The recent institutional ratings show no downgrades, with several firms maintaining or reiterating their positive stances, reinforcing the bullish consensus.
Bulls vs Bears: DD Investment Factors
DuPont presents a mixed picture: strong pricing power, a solid balance sheet, and bullish analyst targets are countered by significant revenue declines from portfolio reshaping and negative trailing earnings. The bull case is supported by the low PEG ratio and forward PE, suggesting the market expects a strong earnings recovery. However, the bear case highlights the uncertainty around the pace of growth and the premium valuation on sales. Currently, the evidence slightly favors the bulls, given the analyst consensus and the company's strategic focus on high-growth segments. The key tension is whether the revenue decline is truly a temporary transition or a sign of structural weakness, which will be resolved as the new portfolio matures.
Bullish
- Strong pricing power and raised guidance: DuPont's Q1 2026 results demonstrated resilient pricing power, leading to an accelerated stock buyback and raised guidance. This indicates management's confidence in sustaining profitability despite revenue declines from portfolio reshaping.
- Undervalued on forward earnings: With a forward PE of 17.37x and a PEG ratio of 0.10x, the stock appears undervalued relative to its expected earnings growth. Analysts project EPS of $9.75 for the next fiscal year, implying a significant earnings recovery.
- Strong 1-year performance and relative strength: DD has delivered a 47.82% return over the past year, outperforming the S&P 500's 20.48% gain. Relative strength over 1 year is +27.34%, indicating robust momentum and market confidence.
- Healthy balance sheet and shareholder returns: The debt-to-equity ratio is a low 0.23, and the company maintains a dividend yield of 3.56%. The recent announcement of an accelerated buyback further supports shareholder value.
Bearish
- Revenue decline due to portfolio changes: Q1 2026 revenue fell 45.17% year-over-year to $1.681 billion, largely due to divestitures. This contraction raises concerns about the pace of strategic repositioning and its impact on near-term growth.
- Negative trailing earnings and ROE: The trailing twelve-month EPS is -$0.046, and ROE is -5.60%, reflecting recent losses and inefficiencies. This could limit the stock's appeal to value investors seeking profitability.
- Recent price momentum has stalled: The stock is down 8.53% over the past 6 months and 4.18% over the past 3 months, underperforming the S&P 500. This suggests waning momentum and potential consolidation.
- High valuation on sales basis: The price-to-sales ratio of 2.45x is above the industry average of 3.0x, indicating the market is paying a premium for revenue. This could limit upside if growth does not materialize.
DD Technical Analysis
DuPont's stock has demonstrated a robust long-term uptrend over the past year, with a 1-year price change of +47.82%, significantly outperforming the S&P 500's +20.48% gain. The current price of $138.33 sits at 87.6% of its 52-week range (between $92.49 and $157.98), indicating the stock is trading closer to its highs but still below the peak. This positioning suggests strong momentum but also potential overextension, as the stock has pulled back from its highs. The 6-month price change of -8.53% and 3-month change of -4.18% indicate a recent corrective phase, yet the longer-term trend remains intact.
Beta
1.09
1.09x market volatility
Max Drawdown
-17.6%
Largest decline past year
52-Week Range
$92-$158
Price range past year
Annual Return
+47.8%
Cumulative gain past year
| Period | DD Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +3.6% |
| 3m | -4.2% | +2.7% |
| 6m | -8.5% | +11.4% |
| 1y | +47.8% | +18.7% |
| ytd | +12.8% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DD Fundamental Analysis
DuPont's revenue trajectory has been volatile, with the most recent quarter (Q1 2026) reporting revenue of $1.681 billion, a significant decline of 45.17% year-over-year. This sharp drop is largely due to portfolio changes, including divestitures, as the company focuses on higher-growth segments. Sequentially, revenue declined from $1.693 billion in Q4 2025, indicating continued contraction. However, the company's electronics and industrial segment, which generated $1.506 billion in revenue, remains a key growth driver, while the water and protection segment contributed $1.359 billion. The overall revenue decline reflects strategic repositioning rather than underlying demand weakness, as the company has raised guidance and demonstrated pricing power.
Quarterly Revenue
$1.7B
2026-03
Revenue YoY Growth
-45.2%
YoY Comparison
Gross Margin
35.8%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DD Overvalued?
Given DuPont's negative trailing twelve-month net income (EPS of -$0.046), the price-to-sales (PS) ratio is the most appropriate valuation metric. The current PS ratio is 2.45x, which is below the industry average of approximately 3.0x, suggesting a modest discount. The forward PE ratio of 17.37x indicates that the market expects earnings to recover strongly, as the company is projected to generate positive EPS of $9.75 per share. The PEG ratio of 0.10x is extremely low, implying that the stock is undervalued relative to its expected growth, though this may be skewed by the low base of current earnings.
PE
-21.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: DuPont's financials show a high degree of volatility, with recent quarters swinging from a net loss of $589 million in Q1 2025 to a profit of $161 million in Q1 2026. The negative trailing EPS of -$0.046 and ROE of -5.60% indicate that the company is not consistently generating returns for shareholders. The revenue decline of 45.17% YoY in Q1 2026, though partly due to divestitures, raises concerns about the stability of the remaining business. Additionally, the company's operating margin of 12.56% is relatively thin, leaving limited room for error if input costs rise. The debt-to-equity ratio is low at 0.23, but the company still has interest expenses of $40 million in Q1 2026, which could strain cash flow if earnings deteriorate further.